Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection

Transplantation

Volumn 85, Issue 9, 2008, Pages 1246-1252

  Chen, Xiaojuan ^a   Zhang, Xiaomin ^a   Larson, Courtney ^a   Xia, Guliang ^a   Kaufman, Dixon B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bioluminescence imaging; Islet transplantation; Rejection

Indexed keywords

GLUCOSE; LYMPHOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BIOLUMINESCENCE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; IN VIVO STUDY; INCIDENCE; KIDNEY CAPSULE; KIDNEY GRAFT REJECTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, EXPERIMENTAL; DRUG ADMINISTRATION SCHEDULE; FIREFLIES; GENES, REPORTER; GRAFT REJECTION; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MODELS, ANIMAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 43449090696     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816b66b0     Document Type: Article

References (28)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation [see comment].NEngl J Med 2006; 355: 1318.
2. Chen X, Kaufman DB. Bioluminescence imaging of pancreatic islet transplants. Curr Med Chem 2004; 4: 301.
3. Chen X, Zhang X, Larson CS, et al. In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 2006; 81: 1421.
4. Tanaka M, Swijnenburg RJ, Gunawan F, et al. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 2005; 112(9 suppl): I105.
5. Bonnefoy-Berard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
6. Rebellato LM, Gross U, Verbanac KM, et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994; 57: 685.
7. Geissler I, Sawyer GJ, Dong X, et al. The effect of anti-lymphocyte serum on subpopulations of blood and tissue leucocytes: Possible supplementary mechanisms for suppression of rejection and the development of opportunistic infections. Transpl Int 2005; 18: 1366.
8. Hale DA, Gottschalk R, Maki T, et al. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Transplantation 1998; 65: 473.
9. Kaufman DB, Shapiro R, Lucey MR, et al. Immunosuppression: practice and trends. Am J Transpl 2004; 4(suppl 9): 38.
10. Gray BN, Watkins E Jr. Isolated islet transplantation in experimental diabetes. Aust J Exp Biol Med Sci 1976; 54: 57.
11. Gotoh M, Porter J, Monaco AP, et al. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum. Transplantation 1988; 45: 429.
12. Aebischer P, Lacy PE, Gerasimidi-Vazeou A, et al. Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site. Diabetes 1991; 40: 482.
13. Maki T, Ichikawa T, Blanco R, et al. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with antilymphocyte serum. Proc Natl Acad Sci USA 1992; 89: 3434.
14. Markees TG, De Fazio SR, Gozzo JJ. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow. Transplantation 1992; 53: 521.
15. Li H, Inverardi L, Molano RD, et al. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Transplantation 2003; 75: 966.
16. Dufour JM, Rajotte RV, Kin T, et al. Immunoprotection of rat islet xenografts by cotransplantation with Sertoli cells and a single injection of antilymphocyte serum. Transplantation 2003; 75: 1594.
17. Shi Q, Wang D, Hadley GA, et al. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Diabetes 2004; 53: 2338.
18. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997; 66: 523.
19. Sweeney TJ, Mailander V, Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci USA 1999; 96: 12044.
20. Massoud TF, Paulmurugan R, De A, et al. Reporter gene imaging of protein-protein interactions in living subjects. Curr Opin Biotechnol 2007; 18: 31.
21. Massoud TF, Paulmurugan R, Gambhir SS. Molecular imaging of homodimeric protein-protein interactions in living subjects. FASEB J 2004; 18: 1105.
22. Paulmurugan R, Massoud TF, Huang J, et al. Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Res 2004; 64: 2113.
23. Cao YA, Wagers AJ, Beilhack A, et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci USA 2004; 101: 221.
24. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006; 113: 1005.
25. Krishnan M, Park JM, Cao F, et al. Effects of epigenetic modulation on reporter gene expression: Implications for stem cell imaging. FASEB J 2006; 20: 106.
26. Lu Y, Dang H, Middleton B, et al. Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther 2004; 9: 428.
27. Fowler M, Virostko J, Chen Z, et al. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 2005; 79: 768.
28. Ali A, Garrovillo M, Jin MX, et al. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 2000; 69: 221.